Eli Lilly

5 Must-Watch Earnings Reports in the Health-Care Sector This Week
Motley Fool
Mon, 04/22/13 - 11:14 am
earnings
Eli Lilly
Wellpoint
Biogen Idec
Celgene
Alexion
Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease
Forbes
Mon, 04/22/13 - 10:23 am
Pharma CEOs
Sanofi
Eli Lilly
Alzheimer's disease
R&D
Chris Viehbacher
Marking the Way for Alzheimer's Drugs
Motley Fool
Sat, 04/20/13 - 11:16 am
Alzheimer's disease
Eli Lilly
Why Did Vanda Pharmaceuticals Hit A 52-Week High?
Seeking Alpha
Fri, 04/19/13 - 08:49 am
Vanda
Sanofi
Novartis
Eli Lilly
tasimelteon
Fanapt
Troubling New Signals? Diabetes Drugs & Adverse Event Reports
Pharmalot
Thu, 04/18/13 - 10:43 am
adverse events
diabetes
FDA
Novo Nordisk
Bristol-Myers Squibb
Boehringer Ingelheim
Merck
Eli Lilly
Clean Superiority Sweep For Dulaglutide Could Reshape Diabetes Market
Seeking Alpha
Wed, 04/17/13 - 04:40 pm
diabetes
Eli Lilly
dulaglutide
Novo Nordisk
Sanofi
Amarantus LymPro Could Be A Game-Changer For Alzheimer's Diagnosis
Seeking Alpha
Wed, 04/17/13 - 10:51 am
LymPro
Amarantus BioSciences
Alzheimer's disease
Pfizer
Forest Labs
Eli Lilly
Merck's Latest Drug and Strategy Concoctions
Motley Fool
Tue, 04/16/13 - 10:22 am
Merck
Pfizer
Eli Lilly
patents
Lilly diabetes drug as good as insulin in study
Reuters
Tue, 04/16/13 - 10:15 am
Eli Lilly
insulin
diabetes
dulaglutide
China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcare
Seeking Alpha
Sun, 04/14/13 - 12:21 pm
OriGene Technologies
Eli Lilly
Tong Ren Tang Technologies
Eddingpharm
Hard Times at Eli Lilly
Motley Fool
Sun, 04/14/13 - 12:20 pm
Eli Lilly
Drugmaker Lilly seeks to cut 30 pct of its U.S. sales force -WSJ
Reuters
Fri, 04/12/13 - 10:03 am
Eli Lilly
drug reps
layoffs
Drugmaker Lilly plans cuts to US sales force
Yahoo/AP
Thu, 04/11/13 - 04:37 pm
drug reps
layoffs
Eli Lilly
Biodel: Reemerging From Obscurity In 2013
Seeking Alpha
Thu, 04/11/13 - 11:34 am
Biodel
Eli Lilly
BIOD-123
recombinant human insulin
BIOD-250
Eli Lilly settles wrongful death lawsuit
Indianapolis Star, IN
Wed, 04/10/13 - 11:14 am
Cymbalta
Eli Lilly
lawsuits
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
immuno-oncology
cancer
Bristol-Myers Squibb
AbbVie
Ariad Pharmaceuticals
JNJ
Eli Lilly
Novartis
Pfizer
Medivation
Erbitux
Yervoy
Sprycel
Orencia
3 Ways Big Pharma Is Seizing This Rare Opportunity
Motley Fool
Fri, 04/5/13 - 10:21 am
Merck
Endocyte
Eli Lilly
Pfizer
Repligen
AbbVie
Protalix BioTherapeutics
Can New Psoriasis Drugs Scratch Investors' Itch?
Investors.com
Thu, 04/4/13 - 01:52 pm
investors
psoriasis
Amgen
Eli Lilly
Pfizer
Novartis
Celgene
Humira
AbbVie
Stelara
Remicade
Enbrel
apremilast
brodalumab
Xeljanz
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Thu, 04/4/13 - 09:13 am
Celgene
Eli Lilly
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Pomalyst
Revlimid
Abraxane
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wed, 04/3/13 - 10:48 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Novo Nordisk
Merck
Incretin

Pages